test
Monday, June 24, 2024

With MDMA on the brink of FDA approval, psychedelic medicine faces a critical moment

Must read




A panel of independent advisers to the Food and Drug Administration is meeting Wednesday to discuss the agency’s potential approval of MDMA-assisted therapy for post-traumatic stress disorder, marking a pivotal moment for the booming field of psychedelic medicine.



Source link

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article